Specific Adoptive Therapy of Disseminated Tumors

作者: Philip D. Greenberg , Donald E. Kern , Michael C. V. Jensen , Jay P. Klarnet , Martin A. Cheever

DOI: 10.1007/978-1-4613-1925-2_26

关键词:

摘要: There is little difficulty demonstrating under experimental conditions that T cells can specifically recognize and kill autochthonous or MHC-compatible tumor cells. However, the all too common observation neoplastic develop grow progressively in apparently immunocompetent hosts suggests cellular immune response an inadequate defense mechanism for protection from fatal tumors. are many reasons why host system may be ineffective controlling growth. The most obvious, problematic with regard to immunologic intervention, not express any determinants immunogenic host. Although some tumors lack such determinants, a substantial amount of evidence accumulating suggest do potentially surface antigens. presence these antigens on implies during progressive growth have elicited quantitatively response, induced suppressor which down-regulated response. Recent technologic biologic advances made it possible purify potential effector identify weak antigen-specific T-cell responses by expanding number reactive vitro culture. Application techniques analysis has permitted detection apparent tumor-specific immunity cancer patients variety solid hematologic malignancies.(1–6) Thus, methods augment being explored as therapies.

参考文章(55)
L. L. Perry, M. I. Greene, R. T. McCluskey, B. Benacerraf, Enhanced syngeneic tumor destruction by in vivo inhibition of suppressor T cells using anti-I-J alloantiserum. American Journal of Pathology. ,vol. 92, pp. 491- 506 ,(1978)
Stephen W. Russell, G. Yancey Gillespie, Judith L. Pace, Evidence for Mononuclear Phagocytes in Solid Neoplasms and Appraisal of Their Nonspecific Cytotoxic Capabilities In Situ Expression of Tumor Immunity. ,vol. 10, pp. 143- 166 ,(1980) , 10.1007/978-1-4684-3677-8_6
Ronald B. Herberman, Howard T. Holden, Luigi Varesio, Tadayoshi Taniyama, Paolo Puccetti, Holger Kirchner, James Gerson, Sandra White, Yona Keisari, J. Stephen Haskill, Immunologic Reactivity of Lymphoid Cells in Tumors In Situ Expression of Tumor Immunity. ,vol. 10, pp. 61- 78 ,(1980) , 10.1007/978-1-4684-3677-8_3
M A Cheever, J A Thompson, P D Greenberg, C Irle, C S Henney, S Gillis, D L Urdal, D Y Mochizuki, Interleukin 2 administered in vivo induces the growth of cultured T cells in vivo. Journal of Immunology. ,vol. 132, pp. 2259- 2265 ,(1984)
Marie-France M. Poupon, Geneviève M. Lespinats, Felix Loisillier, Domagoj Sabolovic, Jean-Pierre B. Kolb, Splenic Modifications Induced by Cyclophosphamide in C3H/He, Nude, and “B”-Mice Journal of Immunology. ,vol. 118, pp. 1595- 1599 ,(1977)
P. D. Greenberg, D. E. Kern, M. C. V. Jensen, J. P. Klarnet, Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL. Journal of Immunology. ,vol. 136, pp. 4303- 4310 ,(1986)
E C Butcher, I Weissman, E Pillemer, M O Dailey, C G Fathman, Abnormal migration of T lymphocyte clones. Journal of Immunology. ,vol. 128, pp. 2134- 2136 ,(1982)
M A Cheever, J A Thompson, P D Greenberg, D E Kern, Interleukin 2 (IL 2) administered in vivo: influence of IL 2 route and timing on T cell growth. Journal of Immunology. ,vol. 134, pp. 3895- 3900 ,(1985)